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Abstract T cell effector functions require sustained calcium influx. However, the signaling and
phenotypic consequences of non-specific sodium permeation via calcium channels remain unknown.
a-SNAP is a crucial component of Orai1 channels, and its depletion disrupts the functional
assembly of Orai1 multimers. Here we show that a-SNAP hypomorph, hydrocephalus with hopping
gait, Napahyh/hyh mice harbor significant defects in CD4 T cell gene expression and Foxp3
regulatory T cell (Treg) differentiation. Mechanistically, TCR stimulation induced rapid sodium influx
in Napahyh/hyh CD4 T cells, which reduced intracellular ATP, [ATP]i. Depletion of [ATP]i inhibited
mTORC2 dependent NFkB activation in Napahyh/hyh cells but ablation of Orai1 restored it.
Remarkably, TCR stimulation in the presence of monensin phenocopied the defects in Napahyh/hyh
signaling and Treg differentiation, but not IL-2 expression. Thus, non-specific sodium influx via
bonafide calcium channels disrupts unexpected signaling nodes and may provide mechanistic
insights into some divergent phenotypes associated with Orai1 function.
DOI: 10.7554/eLife.25155.001
Introduction
A sustained rise in cytosolic calcium is necessary for nuclear translocation of calcium-dependent tran-
scription factors such as nuclear factor of activated T cell (NFAT) (Crabtree, 1999; Parekh and Put-
ney, 2005; Winslow et al., 2003; Macian, 2005; Vig and Kinet, 2009, 2007; Crabtree, 2001).
NFAT proteins are essential for the development of several tissues but have been found to be dis-
pensable for thymic development and function of Foxp3 regulatory T cells (Tregs) (Crabtree and
Olson, 2002; Crabtree, 2001, 1999; Timmerman et al., 1997; Vaeth et al., 2012). The role of pro-
teins directly involved in sustained calcium influx, however, remains less well established. Specifically,
genetic ablation of ORAI1, the pore forming subunit of calcium release activated calcium (CRAC)
channels (Vig et al., 2006b, 2006a; Peinelt et al., 2006), partially inhibits T cell effector cytokines in
mice and does not affect Foxp3 Treg development (Vig et al., 2008; Vig and Kinet, 2009;
Gwack et al., 2008; McCarl et al., 2010). The role of ORAI2 as well as ORAI3, the two closely
related homologs of ORAI1 that are highly expressed in mouse T cells remains unestablished in mice
and humans although all ORAIs are capable of reconstituting CRAC currents in vitro (Mercer et al.,
2006; Lis et al., 2007; DeHaven et al., 2007).
STIM1 and STIM2, the ER resident calcium sensor proteins, are required for ER calcium release,
Orai1 activation and T lymphocyte effector functions (Oh-Hora et al., 2008). However, ablation of
STIMs, but not ORAIs, affects thymic development of Tregs (Oh-Hora et al., 2013; McCarl et al.,
2010) and ablation of STIMs, but not ORAI1, results in multi-organ autoimmunity in mice and
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humans (Oh-Hora et al., 2008; McCarl et al., 2010; Picard et al., 2009). Because STIMs perform
several additional functions such as regulation of calcium selectivity of ORAI1 channels
(McnallyMcNally et al., 2012) as well as inhibition of voltage-gated calcium channel Cav1.2
(Wang et al., 2010; Park et al., 2010), role of sustained calcium influx or store-operated calcium
entry (SOCE) in the development of Tregs and autoimmunity remains correlative (Oh-Hora et al.,
2008, 2013). Likewise, the phenotypes of human patients harboring different Stim and Orai muta-
tions range from immunodeficiency to autoimmunity and cancer. Despite this diversity, all pheno-
types are currently correlated with reduced SOCE (Picard et al., 2009).
We have previously shown that a-soluble NSF-attachment protein (a-SNAP), a cytosolic protein
traditionally studied in the context of soluble NSF attachment protein receptor (SNARE) complex
disassembly and membrane trafficking (Clary et al., 1990), directly binds Stim1 and Orai1 and is
necessary for the functional assembly and ion specificity of multimeric Orai1 channels (Miao et al.,
2013; Li et al., 2016). In addition, a-SNAP has been implicated in AMP kinase (AMPK) inhibition
and zippering of SNAREs in vitro (Park et al., 2014; Baur et al., 2007; Wang and Brautigan, 2013).
SNAREs play a direct role in exocytosis and are therefore required for cytotoxic T, natural killer and
mast cell degranulation (Baram D et al., 2001; Puri et al., 2003; Hepp et al., 2005; Suzuki and
Verma, 2008). However, the role of a-SNAP is less clear in vivo, and remains unexplored in the
immune system. a-SNAP deletion is embryonic lethal in mice and a hypomorphic missense mutation
in a-SNAP, hydrocephalus with hopping gait, (Napahyh/hyh) has been previously reported to cause
neuro-developmental defects (Bronson and Lane, 1990; Chae et al., 2004; Hong et al., 2004).
Here, we show that reduced expression of a-SNAP causes unexpected defects in CD4 T cell sig-
naling, gene expression and Foxp3 Treg differentiation. Using RNAi-mediated ablation of Orai1 in
Napahyh/hyh CD4 T cells and monensin treatment of wildtype CD4 T cells, we demonstrate that Orai1
mediated sodium influx, but not reduced SOCE, depletes [ATP]i in T cell receptor (TCR) stimulated
Napahyh/hyh CD4 T cells. Furthermore, we find that depletion of [ATP]i levels disrupts mTORC2 acti-
vation which, in turn, inhibits NFkB activation and differentiation of Foxp3 Tregs in Napahyh/hyh
mice in vivo as well as in vitro. Therefore, analysis of a-SNAP deficient mice reveals that sodium per-
meation via Orai1 disrupts a novel signaling node and could provide alternate mechanistic insights
into the diversity of phenotypes observed in Stim and Orai mutant human patients.
Results
Napahyh/hyh mice harbor severe defects in the production of CD4 T cell
effector cytokines
Mice bearing Napahyh/hyh mutation on a mixed background have been characterized previously in
the context of neurodevelopmental disorders (Bronson and Lane, 1990; Chae et al., 2004;
Hong et al., 2004). We backcrossed Napahyh/hyh mice on to C57BL/6 background and found that
homozygous mutant Napahyh/hyh mice were significantly smaller in size and died perinatally, within
2–3 weeks. To overcome the issue of perinatal lethality, we generated fetal liver chimeras using irra-
diated CD45.1+ congenic recipients reconstituted with CD45.2+ wildtype or Napahyh/hyh E15.5
embryos. We analyzed fetal liver chimeras at 8–12 week post-transfer and found that the reconstitu-
tion efficiency and number of thymocytes (Figure 1A) and splenocytes (Figure 1B) was comparable
in wildtype (WT) and Napahyh/hyh chimeras. Relative abundance of CD4 and CD8 T cells in the thy-
mus (Figure 1C) and spleen (Figure 1D) was also normal in Napahyh/hyh fetal liver chimeras. There-
fore, we performed all the subsequent analysis of wildtype and Napahyh/hyh CD4 T cells and Foxp3
Tregs using fetal liver chimeras, unless otherwise specified.
a-SNAP null mice are embryonic lethal and, in accordance with previous reports, Napahyh/hyh CD4
T cells showed ~40% depletion of a-SNAP levels (Figure 1E). Given the role of a-SNAP in SNARE
recycling (Clary et al., 1990), we first compared the levels of cell surface receptors. Surprisingly, sur-
face expression TCR and co-receptors was normal in Napahyh/hyh peripheral CD4 T cells (Figure 1F).
Resting Napahyh/hyh T lymphocytes showed largely normal surface expression of CD25, CD44 and
CD69 and their up-regulation following receptor-mediated stimulation was comparable to WT
(Figure 1G).
CRAC channel components, Orai1 and Stim1 are necessary for optimal production and secretion
of several T cell effector cytokines (Vig et al., 2008; Vig and Kinet, 2009; Gwack et al., 2008; Oh-
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Figure 1. Napahyh/hyh mice harbor severe defects in the production of CD4 T cell effector cytokines. (A and B) Representative FACS profile showing the
reconstitution efficiency and average cell yields from the thymus (A) and spleen (B) of WT (black) and Napahyh/hyh (red) fetal liver chimeric mice. (n = 25).
(C and D) Representative FACS profile showing the percentage of CD4+, CD8+ single and double positive thymocytes in CD45.2+ gated cells from WT
and Napahyh/hyh chimera thymus (C) and spleen (D). (n = 10). (E) Representative Western blot for a-SNAP in whole cell lysates prepared from WT and
Figure 1 continued on next page
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Hora et al., 2008). However, given a partial depletion of a-SNAP in Napahyh/hyh mice, we first
sought to determine whether Napahyh/hyh CD4 T cells showed defects in the production of effector
cytokines. Surprisingly, we found significant defects in IL-2 (Figure 1H and J) and TNF-a production
by TCR-stimulated Napahyh/hyh CD4 T cells (Figure 1I and J). Napahyh/hyh CD4 T cells cultured under
T helper 1 (Th1) polarizing conditions showed a minor defect in IFN-g production (Figure 1K and
M), however, we observed a robust defect in IL-4 expression in Th2-polarized Napahyh/hyh CD4 T
cells (Figure 1L and M). Intracellular levels of T-bet or Gata-3 did not appear to be significantly
altered in Napahyh/hyh mice (Figure 1—figure supplement 1). Furthermore, Napahyh/hyh CD4 T cells
(Figure 1N–1O) and splenocytes (Figure 1P) showed a partial defect in anti-CD3-induced prolifera-
tion. Taken together, these data demonstrate that Napahyh/hyh CD4 T lymphocytes harbor a signifi-
cant defect in the production of several key effector cytokines, while exhibiting normal levels of cell
surface receptors.
Napahyh/hyh mice harbor significant defects in the differentiation of
Foxp3 regulatory T cells in vivo and in vitro
Stim1-/-Stim2-/- mice (Oh-Hora et al., 2013), but neither Orai1-/- (McCarl et al., 2010) nor
Nfatc1-/-Nfatc2-/- mice (Vaeth et al., 2012), harbor defects in the development of thymic Foxp3
Tregs. Interestingly, analysis of Napahyh/hyh fetal liver chimeras of 8–12 weeks showed lower percent-
age (Figure 2A) as well as total number (Figure 2—source data 1) of thymic Foxp3 Tregs when
compared to WT. Mixed fetal liver chimeras of WT and Napahyh/hyh showed further reduced percen-
tages of Napahyh/hyh Foxp3 Tregs in the thymus (Figure 2B) as well as peripheral lymphoid tissues
(Figure 2C) and Napahyh/hyh Foxp3 Tregs consistently showed lower surface expression of CD44
(Figure 2D) and GITR (Figure 2E). These data suggest additional potential defects in the homing
(Luo et al., 2016) and in vivo expansion of Foxp3 Tregs (Ronchetti et al., 2015; Ephrem et al.,
2013; Liao et al., 2010). Indeed, lamina propria of Napahyh/hyh chimeras showed further reduced
numbers of Foxp3 Tregs (Figure 2F). Furthermore, in vitro differentiation of Napahyh/hyh CD4 T cells
also yielded lower percentage (Figure 2G) and number (Figure 2—source data 2) of Foxp3 iTregs.
Taken together, these data demonstrate a crucial role for a-SNAP in Foxp3+ Treg differentiation in
vivo as well as in vitro.
Orai1-mediated sodium influx inhibits Foxp3 iTreg differentiation by
disrupting NFkB activation in Napahyh/hyh CD4 T cells
We have previously shown that a-SNAP is an integral component of the CRAC channel complex,
where it facilitates the functional assembly as well as ion selectivity of Orai1 multimers via specific
molecular interactions (Li et al., 2016). Because Orai1-/- mice do not show a defect in Foxp3 regula-
tory T cell development (Vig et al., 2008; Vig and Kinet, 2009; Gwack et al., 2008; McCarl et al.,
2010), we hypothesized that non-specific sodium permeation via Orai1 could lead to reduced gener-
ation of thymic and iTregs in Napahyh/hyh mice.
Figure 1 continued
Napahyh/hyh lymph node cells. (n > 5). (F) FACS profiles showing surface staining of WT (black) and Napahyh/hyh (red) spleen cells with anti-CD4, anti-
CD8, anti-CD3, anti-CD28 and anti-TCRb antibodies respectively. (n = 5). (G) FACS profiles of resting (thin lines) and receptor stimulated (thick lines);
WT (black) and Napahyh/hyh (red) CD4 T cells stained for various activation markers. (n = 3). (H–J) FACS profiles showing intracellular staining for IL-2 (H,
J) and TNF-a (I,J) in WT (black) and Napahyh/hyh (red) CD4 T cells 6 hr post-stimulation. Grey peak shows unstimulated control. (n = 5 repeats from five
chimeras each). (K–M) FACS profiles showing intracellular cytokine staining for Th1 (K,M) and Th2 (L,M) signature cytokines in polarized WT (black) and
Napahyh/hyh (red) CD4 T lymphocytes. Grey peak shows undifferentiated control. (n = 3). (N,O) CFSE dilution profiles (N) and their quantifications (O),
showing proliferation of WT (black) and Napahyh/hyh (red) CD4 T cells in response to plate bound anti-CD3 and anti-CD28 antibodies. Light traces show
unstimulated control. (n = 3). (P) Representative plot showing proliferation of WT (black) and Napahyh/hyh (red) splenocytes in response to soluble anti-
CD3 and anti-CD28, estimated using 3H thymidine incorporation. (n = 3). (See also Figure 1—figure supplement 1).
DOI: 10.7554/eLife.25155.002
The following figure supplement is available for figure 1:
Figure supplement 1. Bar plots showing the average MFIs of the intracellular staining for T-bet and GATA-3 in Th1 and Th2 differentiated WT (black)
and Napahyh/hyh (red) CD4 T cells, respectively. (n = 3).
DOI: 10.7554/eLife.25155.003
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Figure 2. Napahyh/hyh mice harbor significant defects in the differentiation of Foxp3 regulatory T cells in vivo and in vitro. (A) Representative FACS
profiles and dot plot showing the percentage of Foxp3+CD25+ cells in the CD4+CD45.2+ population from WT and Napahyh/hyh chimera thymii. (n = 3
with 2 chimeras/experiment). (B) Dot plot showing the percentage of WT and Napahyh/hyh Foxp3+ cells in mixed chimera thymii. (n = 4 with 2–3
chimeras/experiment). p value from paired student’s t-test. (C) Dot plots showing the percentage of WT and Napahyh/hyh Foxp3+ cells in blood, spleen
and mesenteric lymph nodes (MLN). (n = 4 with 2–3 chimeras/experiment). (D) Representative FACS profile and dot plots showing mean fluorescence
intensity (MFI) of surface expression of CD44 on WT (black) and Napahyh/hyh (red) Foxp3+ cells from various lymphoid tissues of mixed chimeras. (n = 4
with 2 chimeras/experiment). (E) FACS profile and dot plot showing mean fluorescence intensity (MFI) of the surface expression of GITR on WT (black)
and Napahyh/hyh (red) Foxp3+ cells from spleen. (n = 3). (F) Dot plot showing the percentage of WT and Napahyh/hyh Foxp3+ cells in the lamina propria
CD4 T cells isolated from mixed chimeras. (n = 3 with 2 chimeras/experiment). (G) Dot plot showing the normalized percentage of WT (black) and
Napahyh/hyh (red) Foxp3+ cells in in vitro-differentiated CD4 T cells. (n = 7). p value from paired student’s t test. (See also Figure 2—source data 1 and
2).
DOI: 10.7554/eLife.25155.004
The following source data is available for figure 2:
Source data 1. Thymic Foxp3 Tregs in WT and Napahyh/hyh chimeras.
DOI: 10.7554/eLife.25155.005
Source data 2. Foxp3 iTregs in WT and Napahyh/hyh CD4 T cell cultures.
DOI: 10.7554/eLife.25155.006
Miao et al. eLife 2017;6:e25155. DOI: 10.7554/eLife.25155 5 of 23
Research article Immunology
In agreement with our previous findings (Miao et al., 2013), stimulation of Napahyh/hyh CD4 T
cells via TCR (Figure 3A and B) or Thapsigargin (TG) (Figure 3C) induced lower SOCE. More strik-
ingly though, Napahyh/hyh, but not wildtype CD4 T cells, showed rapid and significant sodium entry
in response to TCR as well as TG stimulation (Figure 3D and E). Interestingly, RNAi-mediated deple-
tion of Orai1 in Napahyh/hyh cells abolished sodium influx, demonstrating that sodium enters via
Orai1 in TCR-stimulated Napahyh/hyh CD4 T cells (Figure 3F). Furthermore, replacement of extracel-
lular sodium with a membrane impermeable organic monovalent cation, N-methyl-D-glucamine
(NMDG) prevented fluorescence shift of the sodium dye, SBFI (Figure 3F), establishing its specificity
for sodium and the direction of sodium flux in receptor-stimulated CD4 T cells. Of note, treatment
of wildtype CD4 T cells with monensin, a non-specific sodium ionophore, induced similar levels of
sodium influx (Figure 3G) when compared to TCR-stimulated Napahyh/hyh CD4 T cells.
In agreement with reduced SOCE, we observed that nuclear translocation of NFAT was defective
in Napahyh/hyh CD4 T cells (Figure 3H). However, nuclear translocation of NFkB p65 and c-Rel tran-
scription factors was also severely inhibited in TCR-stimulated Napahyh/hyh CD4 T cells (Figure 3H
and I), although we found no significant defect in T cell receptor-proximal signaling events or MAPK
activation (Figure 3J and K). TCR proximal signaling requires an interplay of several cell surface
receptors, co-receptors and membrane proximal kinases, thus further reinforcing our observations
that membrane receptor signaling events remain unperturbed in Napahyh/hyh T cells.
To determine whether defects in NFkB translocation were due to reduced SOCE or non-selective
sodium influx, we first depleted Orai1 expression in CD4 T cells using RNAi. Orai1 depletion lead to
reduced SOCE (Figure 3L) and nuclear translocation of NFAT (Figure 3M). However, NFkB activa-
tion (Figure 3N) and iTreg differentiation (Figure 3O) were normal in Orai1-depleted CD4 T cells.
On the other hand, stimulation of wildtype CD4 T cells in the presence of monensin did not affect IL-
2 expression (Figure 3P) or NFAT activation (Figure 3Q), but inhibited NFkB activation (Figure 3R)
and iTreg differentiation (Figure 3S). Taken together, these data show that TCR-induced non-selec-
tive sodium influx via Orai1 inhibits NFkB activation to restrict Foxp3 T cell development in Napahyh/
hyh mice.
TCR-induced non-specific sodium influx depletes [ATP]i in Napa
hyh/hyh
CD4 T cells
Next, by examining additional signaling events in TCR-stimulated Napahyh/hyh CD4 T cells, we sought
to understand the molecular basis by which NFkB activation is defective. The sodium potassium
ATPase (Na K ATPase) maintains resting membrane potential by pumping out intracellular sodium
using ATP hydrolysis and can consume ~30–40% of cellular ATP at any given time in resting cells
(Torres-Flores et al., 2011). Hence, we reasoned that TCR-induced abnormal sodium entry could
cause an acute metabolic burden in Napahyh/hyh cells and measured the change in [ATP]i levels in
resting and TCR-stimulated CD4 T cells at different time points post stimulation. Interestingly, wild-
type CD4 T cells showed a rapid and significant rise in [ATP]i upon TCR ligation (Figure 4A). Napa-
hyh/hyh CD4 T cells failed to show this increase but instead showed a sustained drop in [ATP]i post-
stimulation (Figure 4A).
To determine whether the defect in [ATP]i rise was due to sodium influx, we exchanged extracel-
lular sodium with NMDG, and found that the [ATP]i rise was largely restored in Napa
hyh/hyh T cells
(Figure 4A). Stimulation of wildtype CD4 T cells in the presence of monensin also depleted [ATP]i
levels (Figure 4B) and RNAi-mediated depletion of Orai1 in Napahyh/hyh CD4 T cells largely restored
the [ATP]i depletion (Figure 4C).
Naı¨ve CD4 T cells depend on oxidative phosphorylation to generate [ATP]i. To determine
whether the mitochondrial number and function were normal in Napahyh/hyh CD4 T cells, we stained
Napahyh/hyh CD4 T cells with MitoTracker green and found that their mitochondrial content was nor-
mal (Figure 4D). Oxygen consumption rate (OCR), extracellular acidification rate (ECAR) and the
respiratory capacities of naı¨ve (Figure 4E and F), receptor-stimulated (Figure 4G and H) and TH0-
differentiated (Figure 4I and J) Napahyh/hyh CD4 T cells were also largely comparable to wildtype T
cells. Taken together, these data demonstrate that non-specific sodium influx, but not compromised
mitochondrial health, underlies depletion of [ATP]i in receptor-stimulated Napa
hyh/hyh CD4 T cells.
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Figure 3. Orai1-mediated sodium influx inhibits Foxp3 iTreg differentiation by disrupting NFkB activation in Napahyh/hyh CD4 T cells. (A–C)
Representative Fura-2 profiles showing real-time change in average cytosolic calcium levels in WT (black) or Napahyh/hyh (red) CD4 T cells stimulated
with anti-CD3 antibody (A and B) (n = 5 with~50 to 100 cells per experiment) or thapsigargin (TG) (C) (n = 3 with~50 to 100 cells per experiment).
Percent SOCE was calculated by normalizing average WT response to 100 and then calculating the % response of Napahyh/hyh CD4 T cells. (D and E)
Figure 3 continued on next page
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Depletion of [ATP]i inhibits mTORC2 activation in Napa
hyh/hyh CD4 T
cells
Extracellular ATP [ATP]e has been extensively studied in the context of T cell activation
(Schenk et al., 2008; Ledderose et al., 2014) autoimmunity and graft versus host disease
(Atarashi et al., 2008; Wilhelm et al., 2010) but the physiological significance of TCR- induced
acute rise in [ATP]i remains unknown. We hypothesized that although dispensable for TCR proximal
signaling (Figure 3J and K), TCR-induced [ATP]i rise could be necessary to support the relatively dis-
tal signaling events following TCR activation. Recently, mTORC2 has emerged as a crucial, but com-
plex, player in T cell differentiation (Chi, 2012). mTORC2 can sense a variety of upstream signals
and according to one report, directly senses ATP and phosphorylates AKT Thr450 in vitro
(Chen et al., 2013). The upstream activator of mTORC2 in CD4 T cells, however, remains unestab-
lished (Masui et al., 2014; Navarro and Cantrell, 2014). Therefore, we assessed the phosphoryla-
tion of AKT Ser473, a well-established mTORC2 target in TCR-stimulated Napahyh/hyh CD4 T cells.
Napahyh/hyh CD4 T cells showed significantly reduced phosphorylation of AKT Ser473 (Figure 5A),
but not Thr308 (Figure 5B), the mTORC1 target site. Furthermore, TCR stimulation of wildtype CD4
T cells in the presence of monensin also blocked AKT Ser473 phosphorylation (Figure 5C) but not
Thr308 (Figure 5D). In accordance with these observations, phosphorylation of mTORC1 substrate,
4E-BP1 was normal in Napahyh/hyh CD4 T cells (Figure 5E). Of note, Orai1 depletion restored AKT
Ser473 phosphorylation in Napahyh/hyh CD4 T cells (Figure 5F) and the levels of mTORC2 complex
proteins were largely comparable in WT and Napahyh/hyh CD4 T cell WCLs (Figure 5G). These data
demonstrate that Orai1 mediated sodium influx and the consequent drop in [ATP]i disrupts TCR-
induced mTORC2 activation.
mTORC2 regulates NFkB activation via multiple signaling intermediates
in Napahyh/hyh CD4 T cells
mTORC2 has been shown to regulate NFkB activation via many different signaling intermediates
including AGC kinase, AKT (Masui et al., 2014), PKC-q and IkB-a (Lee et al., 2010; Tanaka et al.,
2011). Indeed, in addition to AKT Ser473 (Figure 5A), phosphorylation of PKC-q (Figure 6A), IKK-b
(Figure 6B) and IkB-a (Figure 6C) was also reduced in TCR-stimulated Napahyh/hyh CD4 T cells. Of
note, similar to AKT Ser473 (Figure 5F), IkB-a phosphorylation was restored in Napahyh/hyh CD4 T
cells upon ablation of Orai1 (Figure 6D). Given that monensin can also inhibit NFkB activation
(Deng et al., 2015), our data demonstrate that defective mTORC2 signaling results in the inhibition
of nuclear translocation of NFkB in Napahyh/hyh CD4 T cells.
c-rel-/- mice harbor a significant defect in the development as well as function of Foxp3 T cells
(Isomura et al., 2009; Ruan et al., 2009; Long et al., 2009). Paradoxically, ablation of mTORC2
complex proteins enhances Foxp3 T cell development (Delgoffe et al., 2009) (Lee et al., 2010).
Indeed, despite a strong defect in c-Rel and NFkB p65 activation, we observed only a partial
decrease in Napahyh/hyh Foxp3 T cell development in vivo and well as in vitro (Figure 2). To resolve
Figure 3 continued
Average SBFI profiles showing real-time change in [Na]i of WT (black) and Napa
hyh/hyh (red) CD4 T cells stimulated with anti-CD3 antibody (D) (n = 5
with~50 to 100 cells per experiment) or TG (E) (n = 1 with~50 to 100 cells per experiment). (F) Average SBFI profiles of anti-CD3-stimulated WT (black)
and Napahyh/hyh CD4 T cells treated with scramble (scr) RNAi (red) or Orai1 RNAi (blue); (magenta) anti-CD3-stimulated Napahyh/hyh T cells where [Na]e
was replaced with NMDG. (n = 1 with~50 to 100 cells per experiment). (G) SBFI profiles of WT CD4 T cells, treated with Monensin (red) or untreated
(black). (n = 1 with~50 to 100 cells per experiment). (H,I) Western blot for cytosolic and nuclear NFAT1 and NFkB p65 (H) or c-Rel (I) in receptor-
stimulated WT and Napahyh/hyh CD4 T cells. (n = 4). (J,K) Western blot for total and phospho-Lck, ZAP-70 and PLC- g (J) and total and phospho-Erk1/2,
p38 and Jnk (K) in receptor-stimulated WT and Napahyh/hyh CD4 T cell WCLs. (n = 3). (L) Representative Fura-2 profiles showing real-time change in
average cytosolic calcium levels in scr (black) or Orai1 RNAi treated (red) CD4 T cells stimulated with anti-CD3 antibody. (n = 2 with~50 to 100 cells per
experiment). (M,N) Western blot for cytosolic and nuclear NFAT (M) and NFkB p65 (N) in receptor-stimulated scr or Orai1 RNAi (Orai1) treated WT CD4
T cells. (O) Representative dot plot showing the normalized percentage of Foxp3+ cells in scr (black) and Orai1 RNAi treated (red) CD4 T cells
differentiated in vitro. (n = 3), p value from paired student’s t-test. (P) FACS profiles showing intracellular IL-2 expression in WT CD4 T cells, receptor-
stimulated in the presence (red) or absence (black) of monensin. (n = 2). (Q,R) Western blot for nuclear NFAT1 (Q) and NFkB p65 (R) in receptor
stimulated WT CD4 T cells with or without monensin. (n = 2). (S) Bar plot showing % Foxp3+ cells differentiated in vitro, in the absence or presence of
different doses of monensin. (n = 3).
DOI: 10.7554/eLife.25155.007
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this conundrum, we explored other known targets of mTORC2 and found that the nuclear export of
FOXO-1 was also partially inhibited (Figure 6E). FOXO-1 is necessary for Foxp3 Treg development
(Kerdiles et al., 2010). However, its inactivation was recently shown to be required for the activation
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Figure 4. TCR-induced non-specific sodium influx depletes [ATP]i in Napa
hyh/hyh CD4 T cells. (A) Percent change in intracellular ATP levels [ATP]i in anti-
CD3-stimulated WT and Napahyh/hyh CD4 T cells, measured at different times post-stimulation. (n = 6). (B) Percent change in [ATP]i in WT CD4 T cells,
stimulated with anti-CD3 in the presence or absence of Monensin. (n = 2). (C) Percent change in [ATP]i in anti-CD3-stimulated WT and Napa
hyh/hyh CD4
T cells, treated with scramble (scr) or Orai1 RNAi (Orai1). (n = 2). (D) FACS profiles of WT (black) and Napahyh/hyh (red) CD4 T cells stained with
Mitotracker green. (n = 2). (E–J) OCR and ECAR profiles of naive (E,F), TCR receptor stimulated for 6 hr (G,H), or TH0 (I,J) WT (black) and Napahyh/hyh
(red) CD4 T cells. (n = 2 each).
DOI: 10.7554/eLife.25155.008
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reduced export of FOXO-1 may partially restore Foxp3 expression in Napahyh/hyh iTregs, but inhibit
their activation and expansion in vivo.
TCR-stimulated Napahyh/hyh CD4 T cells show significantly altered gene
expression
To analyze the cumulative effect of a concomitant defect in the activation of NFAT, NFkB and
nuclear export of FOXO-1 on gene expression, we performed RNA sequencing on TCR-stimulated
wildtype and Napahyh/hyh CD4 T cells (Figure 6F and G). Principal component analysis (PCA) on
Napahyh/hyh and WT samples showed that gene expression from Napahyh/hyh replicates were highly
correlated between themselves and clustered distinctly from wildtype samples (Figure 6F). ~500
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Figure 5. Depletion of [ATP]i inhibits mTORC2 activation in Napa
hyh/hyh CD4 T cells. (A,B) Western blot for total and pS473 (A) or pT308 (B) phospho-
AKT in receptor-stimulated WT and Napahyh/hyh CD4 T cell WCLs at different times post-activation. (n = 3). (C,D) Western blot for total and pS473
phospho-AKT (C) or pT308 phospho-AKT (D) in WT CD4 T cell receptor stimulated in the presence or absence of monensin. (n = 2). (E) Western blot for
total and phospho- pT37/46 4E-BP1 in receptor-stimulated WT and Napahyh/hyh CD4 T cell WCLs. (F) Western blot for total and pS473 phospho-AKT in
WCLs of receptor-stimulated WT and Napahyh/hyh CD4 T cells, treated with scramble (scr) or Orai1 RNAi (Orai1). (n = 2). (G) Western blot for mTORC2
complex proteins in the WCLs of receptor-stimulated WT and Napahyh/hyh CD4 T cells. (n = 2).
DOI: 10.7554/eLife.25155.009
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compared to their expression in WT cells. The list of differentially expressed genes can be found at
(10.5061/dryad.202fn).
A scatter plot of these gene expression values from Napahyh/hyh and WT samples is shown in
Figure 6G and the average fold change in the expression of a few representative targets of NFkB,
NFAT and FOXO-1 are shown in Figure 6H. We grouped the differentially expressed genes into
pathways using a pathway analysis software. The non-redundant pathways with at least 10% repre-
sentation of total genes were considered significantly disrupted and top 50 of those are listed in
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Figure 6. mTORC2 regulates NFkB activation via multiple signaling intermediates in Napahyh/hyh CD4 T cells. (A–C) Western blots for total and pT538
phospho-PKC-q (A), phospho-IKKb (B) and phospho-IkB-a (C) in WCLs of receptor-stimulated WT and Napahyh/hyh CD4 T cells. (n = 2). (D) Western blot
for total and phospho-IkB-a in WCLs of receptor-stimulated WT and Napahyh/hyh CD4 T cells, treated with scr or Orai1 RNAi. (E) Western blot for
cytosolic and nuclear FOXO-1 in receptor-stimulated WT and Napahyh/hyh CD4 T cells. (n = 3). (F) Principal component analysis (PCA) on gene
expression data from TCR-stimulated WT and Napahyh/hyh CD4 T cell RNA. (n = 2 from 2 independent chimeras each). (G) Scatter plot showing the
normalized means of gene expression values (RPKM) in Napahyh/hyh and WT CD4 T cells after filtering for genes as described in Materials and methods.
(H) Bar plot showing fold change in the expression of a few representative genes between WT and Napahyh/hyh samples from (F,G) (See also Figure 6—
source data 1).
DOI: 10.7554/eLife.25155.010
The following source data is available for figure 6:
Source data 1. Pathways defective in receptor stimulated Napahyh/hyh CD4 T cells.
DOI: 10.7554/eLife.25155.011
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(Figure 6—source data 1). Thus, receptor-induced non-specific sodium influx disrupts a novel
[ATP]ifi mTORC2 signaling node in Napa
hyh/hyh CD4 T cells, contributing to wide-spread and severe
defects in CD4 T cell gene expression, effector cytokine production and Foxp3 regulatory T cell
development. To our knowledge, an early rise in [ATP]i levels upon TCR stimulation, its sensitivity to
sodium permeation and its direct role in the activation of mTORC2 signaling node have not been
reported previously.
Ectopic expression of a-SNAP can restore defects in Napahyh/hyh CD4 T
cell effector cytokine production
Previous characterization of developmental defects in the neuroepithelium of Napahyh/hyh mice has
suggested that hyh mutation causes reduced expression of a-SNAP due to mRNA instability, but
M105I a-SNAP has normal function (Chae et al., 2004). Indeed, similar to Napahyh/hyh CD4 T cells,
RNAi-mediated reduction of a-SNAP expression inhibited SOCE (Figure 7A) and the expression of
key effector cytokines (Figure 7B) in primary CD4 T cells. Yet, some recent studies have reported
that purified M105I a-SNAP protein displays altered function in vitro (Rodrı´guez et al., 2011;
Park et al., 2014). Therefore, we wondered whether protein intrinsic functional defects in M105I a-
SNAP contribute to Napahyh/hyh immunodeficiency. To test this, we reconstituted Napahyh/hyh CD4 T
cells with WT or M105I a-SNAP. Both WT as well as M105I mutant a-SNAP fully restored intracellular
IL-2 production (Figure 7C) as well as SOCE (Figure 7D) in Napahyh/hyh T cells. Consistent with these
data, purified M105I a-SNAP protein bound to Stim1 and Orai1 as efficiently as WT a-SNAP in pull
down assays in vitro (Figure 7E). Further, ectopic expression of M105I a-SNAP in HEK 293 cells
revealed its cytosolic localization in resting cells (Figure 7F) as well as co-clustering with Stim1 in ER-
PM junctions of store-depleted cells (Figure 7G), identical to WT a-SNAP localization patterns
observed previously (Miao et al., 2013). Taken together, these data show that M105I a-SNAP is
functionally similar to WT a-SNAP in its ability to support SOCE and CD4 T cell gene expression.
Figure 8 summarizes the signaling nodes affected by TCR-induced non-specific sodium influx in
a-SNAP deficient, Napahyh/hyh CD4 T cells contributing to severely altered gene expression, reduced
production of CD4 T cell effector cytokines and Foxp3 Treg development.
Discussion
We have shown that TCR-induced, Orai1-mediated sodium influx disrupts a novel ATP- dependent
signaling cascade necessary for the development of Foxp3 regulatory T cells. High extracellular
sodium has been previously shown to upregulate T helper 17 differentiation (Wu et al., 2013;
Kleinewietfeld et al., 2013). However, to our knowledge, signaling and phenotypic defects result-
ing from TCR-induced non-specific sodium influx via a well-characterized calcium channel have not
been explored previously. Given that deletion or functional ablation of Orai1 inhibits a linear signal-
ing pathway culminating in NFAT activation (Feske et al., 2006), Napahyh/hyh mice would be an
excellent model for further analyses of in vivo phenotypes resulting from permeation and ion selec-
tivity defects in CRAC channels of mice and humans.
Our findings may also provide mechanistic insights into the previous association of elevated
expression of a-SNAP with some aggressive forms of colorectal cancer (Grabowski et al., 2002).
Likewise, monensin-mediated inhibition of Foxp3 iTreg development could, in part, explain the
mechanisms underlying its effective re-purposing in the treatment of several different types of can-
cers (Deng et al., 2015) (Tumova et al., 2014).
The Na K ATPase is ubiquitously expressed and during periods of heightened cellular activity,
such as action potentials in neurons, it is estimated to consume >70% of [ATP]i. ATP hydrolysis is
therefore used as a reliable readout for the Na K ATPase activity (Weigand et al., 2012). Indeed,
sodium influx in TCR-stimulated Napahyh/hyh CD4 T cells correlated well with reduced [ATP]i levels in
our study and no additional defects were observed in the mitochondrial content or morphology
(Li et al., 2016). Therefore, it is reasonable to conclude that depletion of [ATP]i resulted from
increased Na K ATPase activity in receptor-stimulated Napahyh/hyh CD4 T cells. Because Orai1 abla-
tion prevented sodium influx, [ATP]i depletion and reversed mTORC2 signaling defects in Napa
hyh/
hyh CD4 T cells, these data conclusively demonstrate that sodium permeation via Orai1 depletes
[ATP]i.
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Following antigen receptor stimulation, surplus [ATP]i has been shown to get exported from T
cells and bind P2X receptors to sustain calcium influx in an autocrine manner (Schenk et al., 2008;
Yip et al., 2009). Thus, a decrease in [ATP]i could further compound the defect in sustained calcium
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Figure 7. Ectopic expression of a-SNAP can restore defects in Napahyh/hyh CD4 T cells. (A) Average cytosolic calcium levels, measured using FURA
2AM, in scr (black) and a-SNAP RNAi (red)-treated cells stimulated with anti-CD3 antibody to measure SOCE. (n = 3 with ~50 to 100 cells per
experiment). (B) Quantitative PCR to estimate the expression of key effector cytokines in scr (black) and a-SNAP RNAi (red)-treated Th0 cells. (n = 2
repeats; samples from 3 repeats of RNAi). (C) Representative FACS profiles showing intracellular IL-2 staining in WT and Napahyh/hyh CD4 T cells
reconstituted with EV, WT or M105I a-SNAP. (n = 3). (D) Average cytosolic calcium levels, measured using FURA 2AM, in anti-CD3- stimulated WT and
Napahyh/hyh CD4 T cells expressing empty vector (EV), WT or M105I a-SNAP. (n = 2 with ~50 to 200 cells each). (E) Western blot showing in vitro binding
of WT and M105I a-SNAP to Stim1 and Orai1. (n = 2). (F) Confocal images of HEK293 cells expressing WT or M105I a-SNAP and stained with anti-a-
SNAP antibody and DAPI (Scale bar 10 mm). (n = 2; 5 to 6 cells/ per group/ experiment). (G) TIRF images of store-depleted HEK 293 cells co-expressing
CFP-Stim1 and YFP-tagged WT or M105I a-SNAP. (Scale bar 10 mm). (n = 2 with 5 to 6 cells/ per group/ experiment).
DOI: 10.7554/eLife.25155.012
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Genetic ablation of individual components of mTORC2 complex has demonstrated its important
role in CD4 T cell homeostasis as well as helper T cell and Foxp3 Treg differentiation (Gamper and
Powell, 2012; Chapman and Chi, 2014; Masui et al., 2014; Delgoffe et al., 2009; Navarro and
Cantrell, 2014). However, because the upstream activator of mTORC2 was unestablished in T cells
(Navarro and Cantrell, 2014; Masui et al., 2014), its role could be more complex and context-
dependent in vivo. Adding to this complexity, mTORC2 regulates a variety of downstream targets
(Laplante and Sabatini, 2009, 2012). For instance, mTORC2fiNF-kB signaling is involved in cancer
progression downstream of EGFR (Tanaka et al., 2011). Intriguingly, while mTORC2 inhibits Foxp3
Treg differentiation (Delgoffe et al., 2009), NFkB has been shown to be necessary for Treg devel-
opment and function (Isomura et al., 2009; Ruan et al., 2009; Long et al., 2009). Likewise, FOXO-
1 has a dual role in Treg development versus activation (Kerdiles et al., 2010; Luo et al., 2016).
While its ablation inhibits Foxp3 Treg development, its inactivation is necessary for Treg activation,
homing and tumor infiltration (Kerdiles et al., 2010; Luo et al., 2016). Therefore, future analyses of
Napahyh/hyh mice will help in evaluating the consequences of simultaneous inhibition of NFAT and
mTORC2-dependent signaling pathways on CD4 T cell homeostasis, differentiation and function in
specific physiological and disease contexts in vivo.
It is intriguing that membrane trafficking of TCR and co-receptors was normal in Napahyh/hyh CD4
T cells. This result can be explained by considering a competitive binding model for the interactions
of a-SNAP with membrane trafficking proteins versus the Orai-Stim complex. Indeed, a significant
fraction of a-SNAP has been shown to be sequestered by its binding to monomeric syntaxins in rest-
ing cells (Ba´tiz et al., 2009; Rodrı´guez et al., 2011). Furthermore, we have found that the affinity of
a-SNAP for SNAREs is significantly higher when compared to Stim1 and Orai1 (Bhojappa et al.
unpublished findings). Higher affinity and constitutive association of a-SNAP with SNAREs could
explain the relatively intact membrane trafficking of proteins in Napahyh/hyh CD4 T cells which harbor
only a partial depletion of a-SNAP levels when compared to more robust defects in supporting




























Figure 8. Summary of signaling nodes affected by TCR induced non-specific sodium influx.
DOI: 10.7554/eLife.25155.013
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In summary, we have identified a novel [ATP]ifi mTORC2-dependent signaling axis, demon-
strated its requirement for CD4 and Foxp3 regulatory T cell differentiation and established its sensi-
tivity to non-specific sodium influx via Orai1.
Materials and methods
Mice
Napahyh/hyh (RRID: MGI:3033683) mice were obtained from Jackson Laboratory (Bar Harbor, ME)
(strain number: 001035, strain name: B6C3Fe a/a-Napahyh/hyh/J) and backcrossed onto C57BL/6J
until they were >99.4% C57BL/6J, with the help of speed congenics core (RDCC) of the Washington
University. All animal experiments were performed according to the guidelines of the Animal Studies
Committee of the Washington University School of Medicine in Saint Louis, Protocol Approval Num-
ber 20150289.
Genotyping
For genotyping Napahyh/hyh mice a Custom TaqMan SNP Genotyping Assay developed by Applied
Biosystems (Foster City, CA) was used. Forward primer: TCTTTGCTCCCTAGAGGCCATTA, Reverse
primer: CAAGCAACCCTTACCATGTCTGTAT, Reporter 1 (VIC): CTGTCTGATGAGAGCAA, Reporter
2 (FAM): ACTGTCTGATAAGAGCAA.
Fetal liver chimeras
CD45.1 male mice from Charles River were used as recipients for fetal liver chimeras. Recipient mice
were irradiated at 850 rads and fetal livers extracted from E15.5 wildtype or Napahyh/hyh donor
embryos were injected into 3 to 4 recipients each. At least 3 to 4 chimeras were analyzed per experi-
ment and a total of 30 to 40 chimeras of each group were generated and analyzed as part of the
entire study. All chimeras were analyzed 8 to 12 week post-reconstitution.
Technical and biological replicates
Unless otherwise specified within figure legends, ‘n’ denotes technical as well as biological repli-
cates. For instance, n = 3 means three technical repeats from three independent chimera pairs
across 2 to 3 injections.
Cell isolation from chimeras and CD4 T cell sorting
For each experiment, spleen and lymph nodes were harvested from wildtype and Napahyh/hyh fetal
liver chimeras and subjected to two step sorting. CD4+ T cells were first enriched using MACS CD4
+ T cell purification kit (Miltenyi Biotec Inc., San Diego, CA) according to manufacturer’s instructions.
CD4 T cell purity was routinely >95%. To obtain unperturbed CD45.2+CD4+ double positive cells,
MACS-enriched cells were stained with anti-CD45.1 APC and sorted using Aria II (BD Biosciences,
San Jose, CA) by gating on CD45.1 negative cells.
Measurement of single cell SOCE and [Ca2+]i
CD45.2+CD4+ T lymphocytes were sorted from chimeras and plated on coverslips. Cells were
loaded with 1 mM Fura-2-AM (Life Technologies, Eugene, OR) in Ringer’s buffer (135 mM NaCl, 5
mM KCl, 1 mM CaCl2, 1 mM MgCl2, 5.6 mM Glucose, and 10 mM Hepes, pH 7.4) for 40 min in the
dark, washed, and used for imaging. Baseline images were acquired for 1 min and then cells were
simulated with 10 mg/ml soluble anti-CD3 (Biolegend, San Diego, CA) plus 5 mg/ml secondary anti-
body (Biolegend) and imaged simultaneously in nominally calcium free Ringer’s buffer for 5 to 6 min.
Subsequently, extracellular calcium was replenished, and cells were imaged for an additional 5–6
min. 50 to 200 cells were analyzed per group in each experiment. An Olympus IX-71 inverted micro-
scope equipped with a Lamda-LS illuminator (Sutter Instrument, Novato, CA), Fura-2 (340/380) filter
set (Chroma, Bellows Falls, VT), a 10  0.3 NA objective lens (Olympus, UPLFLN, Japan), and a Pho-
tometrics Coolsnap HQ2 CCD camera was used to capture images at a frequency of ~1 image pair
every 1.2 seconds. Data were acquired and analyzed using MetaFluor (Molecular Devices, Sunnyvale,
CA), Microsoft Excel, and Origin softwares. To calculate [Ca]i, Fura-2 Calcium Imaging Calibration Kit
(Life technologies) was used according to manufacturer’s instructions. Briefly, standard samples
Miao et al. eLife 2017;6:e25155. DOI: 10.7554/eLife.25155 15 of 23
Research article Immunology
containing dilutions of free Ca2+(0 to 39 mM) were imaged as described above to obtain the constant
Kd. [Ca











where R is the ratio of 510 nm emission intensity with excitation at 340 nm versus 380 nm; Rmin is the
ratio at zero free Ca2+; Rmax is the ratio at saturating free Ca
2+; F380max is the fluorescence intensity
with excitation at 380 nm, for zero free Ca2+; and F380min is the fluorescence intensity at saturating
free Ca2+. SOCE was calculated as (SOCE=highest [Ca2+]i – basal [Ca
2+]i), where highest [Ca
2+]i was
the highest value after replenishing extracellular calcium and basal [Ca2+]i was the lowest [Ca
2+]i, fol-
lowing store-depletion in calcium-free buffer. Percentage of average SOCE in Napahyh/hyh or a-
SNAP RNAi-treated samples was then determined by setting the average of wildtype SOCE to
100%.
Measurement of single cell [Na]i
CD45.2+CD4+ T cells were sorted from chimeras, plated on coverslips and loaded with 2.5 mM
SBFI-AM (Life Technologies) in Hank’s balanced salt solution (HBSS) buffer at room temperature for
40 min in the dark, washed and used for imaging. Baseline images were acquired for 1 minute, and
then cells were stimulated with 10 mg/ml soluble anti-CD3 (Biolegend) plus 5 mg/ml secondary anti-
body (Biolegend) and imaged simultaneously in HBSS buffer. SBFI was alternatively excited at 340
and 380 nm, and images were collected at 510 nm emission wavelength using the microscope setup
described above. Nearly 150 cells were analyzed per group. To calculate [Na+]i, SBFI was calibrated
in vivo in T lymphocytes based on the protocol described previously (Negulescu and Machen,
1990; Donoso et al., 1992). Briefly, cells were loaded with SBFI and imaged in the buffer containing
serial dilutions of free [Na+] concentration ranging from 0 and 150 mM, which were obtained by mix-
ing Na+ free (130 mM potassium gluconate and 30 mM KCl) and Na+ MAX (130 mM sodium gluco-
nate and 30 mM NaCl) solutions. To equilibrate extracellular and intracellular sodium, cells were
treated with monovalent cation ionophore gramicidin D at 5 mM. After imaging cells in at least five
dilutions, standard curve was obtained by plotting [Na+] on (x-axis) versus [Na+]/(1/R0-1/R) on (y-
axis), where R is the ratio of emission intensity at 510 nm with excitation at 340 nm versus 380 nm;
R0 is the ratio at zero Na
+. From the above equation, the apparent Kd of SBFI in T lymphocytes was
obtained and [Na+]i of experimental samples was then calculated using the constants derived from
the regression line.
Intracellular ATP quantification
CD45.2+CD4+ T lymphocytes were sorted from chimeras and stimulated with 10 mg/ml anti-CD3, 5
mg/ml secondary antibody and 2 mg/ml anti-CD28 for indicated times. Subsequently, cells were
washed using cold HBSS, pelleted and boiled in 100 ml TE buffer at 95˚C for 5 to 7 minutes, and
spun at 14000 RPM for 3 minute. Supernatants containing intracellular ATP and ATP standard were
diluted using ATP assay solution according to manufacturer’s instructions (ATP Determination Kit,
Molecular Probes, Eugene, OR). Luminescence in standard and experimental samples was measured
using FlexStation III, and intracellular ATP in experimental samples was calculated using ATP stan-
dard curve.
Whole cell lysates (WCLs), SDS-PAGE and Western blot
CD45.2+CD4+ T lymphocytes were sorted from chimeras and stimulated with 10 mg/ml soluble anti-
CD3 plus 5 mg/ml secondary antibody, and 2 mg/ml soluble anti-CD28 (Biolegend) in HBSS at 37˚C
for indicated times. Post-stimulation, cells were suspended in cold HBSS, pelleted down and lysed in
RIPA buffer (Cell signaling, Danvers, MA). WCLs were boiled with Laemmli sample buffer containing
100 mM DTT and resolved using 10 or 12% SDS-polyacrylamide gel. Proteins were transferred by
Western blotting to nitrocellulose membrane and probed with respective antibodies as described
previously (Miao et al., 2013). Antibodies used in this paper (Source data 1).
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Nuclear and cytosolic extracts
CD45.2+CD4+ T lymphocytes were sorted from chimeras and stimulated with 10 mg/ml soluble anti-
CD3 (Biolegend) and 5 mg/ml secondary antibody along with 2 mg/ml soluble anti-CD28
(Biolegend) for 30 min. Cytoplasmic and nuclear extracts were prepared using (Thermo
Scientific, Rockford, lL) NE-PER kit as per manufacturer’s instructions and subjected to SDS-PAGE
gel and Western blot as described previously (Miao et al., 2013).
Gene expression analysis
Total RNA was extracted from cells by using RNeasy mini kit (QIAGEN, Germany), reverse tran-
scribed to cDNA with M-MLV RT-PCR (Promega, Madison, WI) and used for Q-PCR. GAPDH and
18S rRNA were first used as housekeeping genes for normalization of expression. Because Ct values
for GAPDH were closer to the Ct values of genes being analyzed here, final normalization was done
using GAPDH.
RNA sequencing
CD45.2+CD4+ T lymphocytes were sorted from chimeras using MACS beads and BD Aria II and
stimulated using plate-coated 10 mg/ml anti-CD3 along with 2 mg/ml soluble anti-CD28 for 6 hr. Fol-
lowing stimulation, total RNA was extracted by using RNeasy mini kit (QIAGEN) and submitted for
quantification, library preparation, sequencing, and initial bioinformatics analysis to Genewiz (South
Plainfield, NJ). Briefly, RNA samples were quantified using Qubit 2.0 Fluorometer (Life Technologies,
Carlsbad, CA) and RNA integrity was checked with 2100 Bioanalyzer (Agilent Technologies, Palo
Alto, CA). Whole transcriptome RNA enrichment was performed using Ribozero rRNA Removal Kit
(1:1 mixture of Human/Mouse/Rat probe and Bacteria probe) (Illumina, San Diego, CA). For RNA
sequencing library preparation, NEB Next Ultra RNA Library Prep Kit for Illumina was used by follow-
ing the manufacturer’s recommendations (NEB, Ipswich, MA). Briefly, enriched RNAs were frag-
mented for 15 min at 94˚C. First strand and second strand cDNA were subsequently synthesized.
cDNA fragments were end repaired and adenylated at 3’ends, and universal adapter was ligated to
cDNA fragments, followed by index addition and library enrichment with limited cycle PCR.
Sequencing libraries were validated using a DNA Chip on the Agilent 2100 Bioanalyzer (Agilent
Technologies), and quantified by using Qubit 2.0 Fluorometer (Invitrogen, Carlsbad, CA) as well as
by quantitative PCR (Applied Biosystems, Carlsbad, CA).
The sequencing libraries were multiplexed, clustered on a single flow cell and loaded on the Illu-
mina HiSeq 2500 instrument. Samples were sequenced using a 1  100 Single Read (SR) Rapid Run
configuration. Image analysis and base calling were conducted using the HiSeq Control Software
(HCS) on the HiSeq 2500 instrument. Raw sequence data (.bcl files) generated from Illumina HiSeq
2500 were converted into fastq files and de-multiplexed using Illumina bcl2fastq v1.8.4 program.
One mismatch was allowed for index sequence identification. Gene expression analysis was per-
formed using the CLC Genomics Workbench software, by trimming sequence reads to remove low-
quality bases at ends, followed by mapping sequence reads to the mouse genome (Refseq) and cal-
culating gene expression values as Reads Per Kilobase of transcript per Million mapped reads
(RPKM). Gene expression data were further filtered to remove transcripts using the following crite-
rion: (i) students t-test p value > 0.05 between biological replicates, (ii) <2 fold change, (iii) genes
with <10 total exon reads in wildtype group. The list of differentially expressed, filtered genes was
deposited at Datadryad (10.5061/dryad.202fn). The data were also subjected to pathway analysis
using the Metacore software (Thomson Reuters, NY) and top 50 pathways with a p-value<0.05 are
displayed in Figure 6—source data 1.
Intracellular cytokine staining
Naı¨ve or differentiated T cells were stimulated with PMA (20 ng/ml) and Ionomycin (1 mg/ml) and
brefeldin A (Biolegend) for 5 to 6 hr and stained using anti-CD4 or anti-CD8 surface markers (Biole-
gend). Subsequently, cells were fixed and permeabilized and incubated with anti-IL-2, anti-IL-4 or
anti-IFN-g antibodies (Biolegend) and analyzed using FACS Calibur or LSR Fortessa analyzers and
Flow Jo software (BD Biosciences).
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T cell proliferations
Naı¨ve CD45.2+CD4+ T lymphocytes were sorted from chimeras and labeled with 10 mM CFSE,
washed and stimulated with 5 mg/ml plate-coated anti-CD3 along with 2 mg/ml soluble anti-CD28 for
72 hr, stained with anti-CD4 antibody and analyzed using LSR Fortessa flowcytometer. In some
experiments, unfractionated splenocytes were stimulated with soluble anti-CD3 and anti-CD28 for
48 hr, pulsed with 1 mCi 3H thymidine for additional 12–16 hr, harvested and counted.
Th1/Th2 differentiation
CD4 T cells were purified from chimeras and stimulated with 5 mg/ml plate-coated anti-CD3 and 2
mg/ml soluble anti-CD28 in the presence of cytokines and neutralizing antibodies for 2 days. For
Th1: 20 ng/ml IL-2, 20 ng/ml IL-12, 10 mg/ml anti-IL-4 and for Th2: 20 ng/ml IL-2, 50 ng/ml IL-4 was
used. After 48 hrs cells were washed and cultured in the above cocktail of cytokines and antibodies
for an additional three days. Cells were then stimulated with 20 ng/ml PMA, 1 mg/ml ionomycin and
brefelin A (Biolegend) for 5–6 hr and stained for Th1/Th2 signature cytokines or transcription factors
T-bet/Gata-3 as mentioned above.
Foxp3 Treg differentiation and staining
CD45.2+CD4+ T lymphocytes were sorted from chimeras and differentiated with 10 mg/ml plate
coated anti-CD3, 2 mg/ml soluble anti-CD28 and 10 ng/ml TGF-b for five days and analyzed. Thymo-
cytes, lymph node, splenocytes or in vitro differentiated Treg cells were stained with anti-CD4 and
anti-CD25 surface markers, then fixed and permeabilized with Fix/Perm buffers (Biolegend) and
stained with Alexa647-FoxP3 (Biolegend).
RNAi in primary T lymphocytes
a-SNAP targeting sequence, (CGCCAAAGACTACTTCTTCAA), was subcloned into MSCV-
LTRmiR30-PIG retroviral vector (Openbiosystems, Lafayette, CO). Viral supernatants were made
according to manufacturer’s instruction. For infections, T cells were stimulated with anti-CD3 for 24
hr prior to infection and spun with the viral supernatant and polybrene (8 mg/ml) at high speed for
90 min. GFP positive cells were analyzed 3 day post infection.
T cell transfections
Naı¨ve T cells were transfected using Amaxa Mouse T Cell Nucleofector Kit (Lonza, Switzerland)
according to manufacturer’s instructions. Cells were analyzed ~16 hr post transfection.
Cell lines and transfection
HEK293 cells were obtained from (ATCC:CRL-1573)(RRID: CVCL_0045), expanded and cultured in
DMEM containing 10% FBS, L-glutamine, non-essential amino acids and sodium pyruvate. Cells were
co-transfected with CFP-Stim1 and YFP-a-SNAP or YFP-a-SNAP M105I expressing vectors, using
Lipofectamine 2000 (Life technologies, USA) and imaged using TIRF illumination as described previ-
ously (Miao et al., 2013). Cell line stocks were tested for mycoplasma contamination using Lonza
Mycoalert (Lonza) every few years.
In vitro binding and western blotting
myc-tagged Orai1 and Stim1 proteins were immunoprecipitated from HEK293 (RRID: CVCL_0045)
cells and beads were incubated with purified recombinant a-SNAP WT or M105I for 1 hr at 4˚C.
Post-incubation, beads were washed three times and protein complexes eluted by boiling in SDS
containing sample buffer and subjected to SDS-PAGE and western blotting as described previously
(Miao et al., 2013).
Statistical analysis
Statistical significance represented as p value was calculated using unpaired student’s t-test, unless
otherwise specified. *p<0.05, **p<0.01, ***p<0.001.
Miao et al. eLife 2017;6:e25155. DOI: 10.7554/eLife.25155 18 of 23
Research article Immunology
Acknowledgements
We thank Grzegorz B Gmyrek, Leah Owens and Cathrine Miner for technical assistance. Yinan wang
for help with generation of fetal liver chimeras. Chyi Song Hsieh for advice on Foxp3 regulatory T




Funder Grant reference number Author
American Cancer Society ACS-RSG 14-040-01-CSM Monika Vig
National Institutes of Health AI108636 Monika Vig
The funders had no role in study design, data collection and interpretation, or the decision to
submit the work for publication.
Author contributions
YM, Conceptualization, Data curation, Formal analysis, Validation, Visualization, Methodology, Writ-
ing—original draft, Project administration; JB, Data curation, Methodology; AD, Data curation, For-
mal analysis, Methodology; MV, Conceptualization, Supervision, Funding acquisition, Methodology,






Animal experimentation: All animal experiments were performed according to the guidelines of the




. Source data 1. Antibodies used in this paper.
DOI: 10.7554/eLife.25155.014
Major datasets
The following dataset was generated:







2017 Data from Na+ Influx via Orai1
Inhibits Intracellular ATP Induced
mTORC2 Signaling To Disrupt






under a CC0 Public
Domain Dedication
References
Atarashi K, Nishimura J, Shima T, Umesaki Y, Yamamoto M, Onoue M, Yagita H, Ishii N, Evans R, Honda K,
Takeda K. 2008. ATP drives Lamina propria T(H)17 cell differentiation. Nature 455:808–812. doi: 10.1038/
nature07240, PMID: 18716618
Baram D, Mekori YA, Sagi-Eisenberg R. 2001. Synaptotagmin regulates mast cell functions. Immunological
Reviews 179:25–34. doi: 10.1034/j.1600-065X.2001.790103.x, PMID: 11292024
Miao et al. eLife 2017;6:e25155. DOI: 10.7554/eLife.25155 19 of 23
Research article Immunology
Baur T, Ramadan K, Schlundt A, Kartenbeck J, Meyer HH. 2007. NSF- and SNARE-mediated membrane fusion is
required for nuclear envelope formation and completion of nuclear pore complex assembly in xenopus laevis
egg extracts. Journal of Cell Science 120:2895–2903. doi: 10.1242/jcs.010181, PMID: 17666429
Bronson RT, Lane PW. 1990. Hydrocephalus with hop gait (hyh): a new mutation on chromosome 7 in the mouse.
Developmental Brain Research 54:131–136. doi: 10.1016/0165-3806(90)90073-8, PMID: 2364541
Ba´tiz LF, De Blas GA, Michaut MA, Ramı´rez AR, Rodrı´guez F, Ratto MH, Oliver C, Tomes CN, Rodrı´guez EM,
Mayorga LS. 2009. Sperm from Hyh mice carrying a point mutation in alphaSNAP have a defect in acrosome
reaction. PLoS One 4:e4963. doi: 10.1371/journal.pone.0004963, PMID: 19305511
Chae TH, Kim S, Marz KE, Hanson PI, Walsh CA. 2004. The hyh mutation uncovers roles for asnap in apical
protein localization and control of neural cell fate. Nature Genetics 36:264–270. doi: 10.1038/ng1302,
PMID: 14758363
Chapman NM, Chi H. 2014. mTOR signaling, tregs and immune modulation. Immunotherapy 6:1295–1311.
doi: 10.2217/imt.14.84, PMID: 25524385
Chen CH, Kiyan V, Zhylkibayev AA, Kazyken D, Bulgakova O, Page KE, Bersimbaev RI, Spooner E, Sarbassov
dosD. 2013. Autoregulation of the mechanistic target of rapamycin (mTOR) complex 2 integrity is controlled by
an ATP-dependent mechanism. Journal of Biological Chemistry 288:27019–27030. doi: 10.1074/jbc.M113.
498055, PMID: 23928304
Chi H. 2012. Regulation and function of mTOR signalling in T cell fate decisions. Nature Reviews Immunology 12:
325–338. doi: 10.1038/nri3198, PMID: 22517423
Clary DO, Griff IC, Rothman JE. 1990. SNAPs, a family of NSF attachment proteins involved in intracellular
membrane fusion in animals and yeast. Cell 61:709–721. doi: 10.1016/0092-8674(90)90482-T, PMID: 2111733
Crabtree GR. 1999. Generic signals and specific outcomes: signaling through Ca2+, calcineurin, and NF-AT. Cell
96:611–614. PMID: 10089876
Crabtree GR. 2001. Calcium, calcineurin, and the control of transcription. Journal of Biological Chemistry 276:
2313–2316. doi: 10.1074/jbc.R000024200, PMID: 11096121
Crabtree GR, Olson EN. 2002. NFAT signaling: choreographing the social lives of cells. Cell 109:S67–S79.
PMID: 11983154
DeHaven WI, Smyth JT, Boyles RR, Putney JW. 2007. Calcium inhibition and calcium potentiation of Orai1,
Orai2, and Orai3 calcium release-activated calcium channels. Journal of Biological Chemistry 282:17548–17556.
doi: 10.1074/jbc.M611374200, PMID: 17452328
Delgoffe GM, Kole TP, Zheng Y, Zarek PE, Matthews KL, Xiao B, Worley PF, Kozma SC, Powell JD. 2009. The
mTOR kinase differentially regulates effector and regulatory T cell lineage commitment. Immunity 30:832–844.
doi: 10.1016/j.immuni.2009.04.014, PMID: 19538929
Deng Y, Zhang J, Wang Z, Yan Z, Qiao M, Ye J, Wei Q, Wang J, Wang X, Zhao L, Lu S, Tang S, Mohammed MK,
Liu H, Fan J, Zhang F, Zou Y, Liao J, Qi H, Haydon RC, et al. 2015. Antibiotic monensin synergizes with EGFR
inhibitors and oxaliplatin to suppress the proliferation of human ovarian Cancer cells. Scientific Reports 5:
17523. doi: 10.1038/srep17523, PMID: 26639992
Donoso P, Mill JG, O’Neill SC, Eisner DA. 1992. Fluorescence measurements of cytoplasmic and mitochondrial
sodium concentration in rat ventricular myocytes. The Journal of Physiology 448:493–509. doi: 10.1113/
jphysiol.1992.sp019053, PMID: 1593474
Ephrem A, Epstein AL, Stephens GL, Thornton AM, Glass D, Shevach EM. 2013. Modulation of Treg cells/T
effector function by GITR signaling is context-dependent. European Journal of Immunology 43:2421–2429.
doi: 10.1002/eji.201343451, PMID: 23722868
Feske S, Gwack Y, Prakriya M, Srikanth S, Puppel SH, Tanasa B, Hogan PG, Lewis RS, Daly M, Rao A. 2006. A
mutation in Orai1 causes immune deficiency by abrogating CRAC channel function. Nature 441:179–185.
doi: 10.1038/nature04702, PMID: 16582901
Gamper CJ, Powell JD. 2012. All PI3Kinase signaling is not mTOR: dissecting mTOR-dependent and
independent signaling pathways in T cells. Frontiers in Immunology 3:312. doi: 10.3389/fimmu.2012.00312,
PMID: 23087689
Grabowski P, Scho¨nfelder J, Ahnert-Hilger G, Foss HD, Heine B, Schindler I, Stein H, Berger G, Zeitz M, Scheru¨bl
H. 2002. Expression of neuroendocrine markers: a signature of human undifferentiated carcinoma of the colon
and rectum. Virchows Archiv 441:256–263. doi: 10.1007/s00428-002-0650-9, PMID: 12242522
Gwack Y, Srikanth S, Oh-Hora M, Hogan PG, Lamperti ED, Yamashita M, Gelinas C, Neems DS, Sasaki Y, Feske
S, Prakriya M, Rajewsky K, Rao A. 2008. Hair loss and defective T- and B-cell function in mice lacking ORAI1.
Molecular and Cellular Biology 28:5209–5222. doi: 10.1128/MCB.00360-08, PMID: 18591248
Hepp R, Puri N, Hohenstein AC, Crawford GL, Whiteheart SW, Roche PA. 2005. Phosphorylation of SNAP-23
regulates exocytosis from mast cells. Journal of Biological Chemistry 280:6610–6620. doi: 10.1074/jbc.
M412126200, PMID: 15611044
Hong HK, Chakravarti A, Takahashi JS. 2004. The gene for soluble N-ethylmaleimide sensitive factor attachment
protein alpha is mutated in hydrocephaly with hop gait (hyh) mice. PNAS 101:1748–1753. doi: 10.1073/pnas.
0308268100, PMID: 14755058
Isomura I, Palmer S, Grumont RJ, Bunting K, Hoyne G, Wilkinson N, Banerjee A, Proietto A, Gugasyan R, Wu L,
Li W, McNally A, Steptoe RJ, Thomas R, Shannon MF, Gerondakis S. 2009. c-Rel is required for the
development of thymic Foxp3+ CD4 regulatory T cells. The Journal of Experimental Medicine 206:3001–3014.
doi: 10.1084/jem.20091411, PMID: 19995950
Miao et al. eLife 2017;6:e25155. DOI: 10.7554/eLife.25155 20 of 23
Research article Immunology
Kerdiles YM, Stone EL, Beisner DR, Beisner DL, McGargill MA, Ch’en IL, Stockmann C, Katayama CD, Hedrick
SM. 2010. Foxo transcription factors control regulatory T cell development and function. Immunity 33:890–904.
doi: 10.1016/j.immuni.2010.12.002, PMID: 21167754
Kleinewietfeld M, Manzel A, Titze J, Kvakan H, Yosef N, Linker RA, Muller DN, Hafler DA. 2013. Sodium chloride
drives autoimmune disease by the induction of pathogenic TH17 cells. Nature 496:518–522. doi: 10.1038/
nature11868, PMID: 23467095
Laplante M, Sabatini DM. 2009. mTOR signaling at a glance. Journal of Cell Science 122:3589–3594. doi: 10.
1242/jcs.051011, PMID: 19812304
Laplante M, Sabatini DM. 2012. mTOR signaling in growth control and disease. Cell 149:274–293. doi: 10.1016/j.
cell.2012.03.017, PMID: 22500797
Ledderose C, Bao Y, Lidicky M, Zipperle J, Li L, Strasser K, Shapiro NI, Junger WG. 2014. Mitochondria are gate-
keepers of T cell function by producing the ATP that drives purinergic signaling. Journal of Biological Chemistry
289:25936–25945. doi: 10.1074/jbc.M114.575308, PMID: 25070895
Lee K, Gudapati P, Dragovic S, Spencer C, Joyce S, Killeen N, Magnuson MA, Boothby M. 2010. Mammalian
target of rapamycin protein complex 2 regulates differentiation of Th1 and Th2 cell subsets via distinct
signaling pathways. Immunity 32:743–753. doi: 10.1016/j.immuni.2010.06.002, PMID: 20620941
Li P, Miao Y, Dani A, Vig M. 2016. a-SNAP regulates dynamic, on-site assembly and calcium selectivity of Orai1
channels. Molecular Biology of the Cell 27:2542–2553. doi: 10.1091/mbc.E16-03-0163, PMID: 27335124
Liao G, Nayak S, Regueiro JR, Berger SB, Detre C, Romero X, de Waal Malefyt R, Chatila TA, Herzog RW,
Terhorst C. 2010. GITR engagement preferentially enhances proliferation of functionally competent CD4+CD25
+FoxP3+ regulatory T cells. International Immunology 22:259–270. doi: 10.1093/intimm/dxq001, PMID: 2013
9172
Lis A, Peinelt C, Beck A, Parvez S, Monteilh-Zoller M, Fleig A, Penner R. 2007. CRACM1, CRACM2, and
CRACM3 are store-operated Ca2+ channels with distinct functional properties. Current Biology 17:794–800.
doi: 10.1016/j.cub.2007.03.065, PMID: 17442569
Long M, Park SG, Strickland I, Hayden MS, Ghosh S. 2009. Nuclear factor-kappaB modulates regulatory T cell
development by directly regulating expression of Foxp3 transcription factor. Immunity 31:921–931. doi: 10.
1016/j.immuni.2009.09.022, PMID: 20064449
Luo CT, Liao W, Dadi S, Toure A, Li MO. 2016. Graded Foxo1 activity in Treg cells differentiates tumour
immunity from spontaneous autoimmunity. Nature 529:532–536. doi: 10.1038/nature16486, PMID: 26789248
Macian F. 2005. NFAT proteins: key regulators of T-cell development and function. Nature Reviews Immunology
5:472–484. doi: 10.1038/nri1632, PMID: 15928679
Masui K, Cavenee WK, Mischel PS. 2014. mTORC2 in the center of Cancer metabolic reprogramming. Trends in
Endocrinology & Metabolism 25:364–373. doi: 10.1016/j.tem.2014.04.002, PMID: 24856037
McCarl C-A, Khalil S, Ma J, Oh-hora M, Yamashita M, Roether J, Kawasaki T, Jairaman A, Sasaki Y, Prakriya M,
Feske S. 2010. Store-Operated Ca2+ entry through ORAI1 is critical for T Cell-Mediated autoimmunity and
allograft rejection. The Journal of Immunology 185:5845–5858. doi: 10.4049/jimmunol.1001796
McNally BA, Somasundaram A, Yamashita M, Prakriya M. 2012. Gated regulation of CRAC channel ion selectivity
by STIM1. Biophysical Journal 482:314–315. doi: 10.1016/j.bpj.2011.11.1727, PMID: 22278058
Mercer JC, Dehaven WI, Smyth JT, Wedel B, Boyles RR, Bird GS, Putney JW. 2006. Large store-operated calcium
selective currents due to co-expression of Orai1 or Orai2 with the intracellular calcium sensor, Stim1. Journal of
Biological Chemistry 281:24979–24990. doi: 10.1074/jbc.M604589200, PMID: 16807233
Miao Y, Miner C, Zhang L, Hanson PI, Dani A, Vig M. 2013. An essential and NSF independent role for a-SNAP in
store-operated calcium entry. eLife 2:e00802. doi: 10.7554/eLife.00802, PMID: 23878724
Navarro MN, Cantrell DA. 2014. Serine-threonine kinases in TCR signaling. Nature Immunology 15:808–814.
doi: 10.1038/ni.2941, PMID: 25137455
Negulescu PA, Machen TE. 1990. Intracellular ion activities and membrane transport in parietal cells measured
with fluorescent dyes. Methods in Enzymology 192:38–81. PMID: 2074799
Oh-Hora M, Yamashita M, Hogan PG, Sharma S, Lamperti E, Chung W, Prakriya M, Feske S, Rao A. 2008. Dual
functions for the endoplasmic reticulum calcium sensors STIM1 and STIM2 in T cell activation and tolerance.
Nature Immunology 9:432–443. doi: 10.1038/ni1574, PMID: 18327260
Oh-Hora M, Komatsu N, Pishyareh M, Feske S, Hori S, Taniguchi M, Rao A, Takayanagi H. 2013. Agonist-
selected T cell development requires strong T cell receptor signaling and store-operated calcium entry.
Immunity 38:881–895. doi: 10.1016/j.immuni.2013.02.008, PMID: 23499491
Parekh AB, Putney JW. 2005. Store-operated calcium channels. Physiological Reviews 85:757–810. doi: 10.1152/
physrev.00057.2003, PMID: 15788710
Park CY, Shcheglovitov A, Dolmetsch R. 2010. The CRAC channel activator STIM1 binds and inhibits L-type
voltage-gated calcium channels. Science 330:101–105. doi: 10.1126/science.1191027, PMID: 20929812
Park Y, Vennekate W, Yavuz H, Preobraschenski J, Hernandez JM, Riedel D, Walla PJ, Jahn R. 2014. a-SNAP
interferes with the zippering of the SNARE protein membrane fusion machinery. Journal of Biological
Chemistry 289:16326–16335. doi: 10.1074/jbc.M114.556803, PMID: 24778182
Peinelt C, Vig M, Koomoa DL, Beck A, Nadler MJ, Koblan-Huberson M, Lis A, Fleig A, Penner R, Kinet JP. 2006.
Amplification of CRAC current by STIM1 and CRACM1 (Orai1). Nature Cell Biology 8:771–773. doi: 10.1038/
ncb1435, PMID: 16733527
Picard C, McCarl CA, Papolos A, Khalil S, Lu¨thy K, Hivroz C, LeDeist F, Rieux-Laucat F, Rechavi G, Rao A, Fischer
A, Feske S. 2009. STIM1 mutation associated with a syndrome of immunodeficiency and autoimmunity. New
England Journal of Medicine 360:1971–1980. doi: 10.1056/NEJMoa0900082, PMID: 19420366
Miao et al. eLife 2017;6:e25155. DOI: 10.7554/eLife.25155 21 of 23
Research article Immunology
Puri N, Kruhlak MJ, Whiteheart SW, Roche PA. 2003. Mast cell degranulation requires N-ethylmaleimide-sensitive
factor-mediated SNARE disassembly. The Journal of Immunology 171:5345–5352. doi: 10.4049/jimmunol.171.
10.5345, PMID: 14607937
Rodrı´guez F, Bustos MA, Zanetti MN, Ruete MC, Mayorga LS, Tomes CN. 2011. a-SNAP prevents docking of
the acrosome during sperm exocytosis because it sequesters monomeric syntaxin. PLoS One 6:e21925. doi: 10.
1371/journal.pone.0021925, PMID: 21789195
Ronchetti S, Ricci E, Petrillo MG, Cari L, Migliorati G, Nocentini G, Riccardi C. 2015. Glucocorticoid-induced
tumour necrosis factor receptor-related protein: a key marker of functional regulatory T cells. Journal of
Immunology Research 2015:1–17. doi: 10.1155/2015/171520, PMID: 25961057
Ruan Q, Kameswaran V, Tone Y, Li L, Liou HC, Greene MI, Tone M, Chen YH. 2009. Development of Foxp3(+)
regulatory t cells is driven by the c-Rel enhanceosome. Immunity 31:932–940. doi: 10.1016/j.immuni.2009.10.
006, PMID: 20064450
Schenk U, Westendorf AM, Radaelli E, Casati A, Ferro M, Fumagalli M, Verderio C, Buer J, Scanziani E, Grassi F.
2008. Purinergic control of T cell activation by ATP released through pannexin-1 hemichannels. Science
Signaling 1:ra6. doi: 10.1126/scisignal.1160583, PMID: 18827222
Suzuki K, Verma IM. 2008. Phosphorylation of SNAP-23 by IkappaB kinase 2 regulates mast cell degranulation.
Cell 134:485–495. doi: 10.1016/j.cell.2008.05.050, PMID: 18692471
Tanaka K, Babic I, Nathanson D, Akhavan D, Guo D, Gini B, Dang J, Zhu S, Yang H, De Jesus J, Amzajerdi AN,
Zhang Y, Dibble CC, Dan H, Rinkenbaugh A, Yong WH, Vinters HV, Gera JF, Cavenee WK, Cloughesy TF, et al.
2011. Oncogenic EGFR signaling activates an mTORC2-NF-kB pathway that promotes chemotherapy
resistance. Cancer Discovery 1:524–538. doi: 10.1158/2159-8290.CD-11-0124, PMID: 22145100
Timmerman LA, Healy JI, Ho SN, Chen L, Goodnow CC, Crabtree GR. 1997. Redundant expression but selective
utilization of nuclear factor of activated T cells family members. Journal of Immunology 159:2735–2740. PMID:
9300694
Torres-Flores V, Picazo-Jua´rez G, Herna´ndez-Rueda Y, Darszon A, Gonza´lez-Martı´nez MT. 2011. Sodium influx
induced by external calcium chelation decreases human sperm motility. Human Reproduction 26:2626–2635.
doi: 10.1093/humrep/der237, PMID: 21810864
Tumova L, Pombinho AR, Vojtechova M, Stancikova J, Gradl D, Krausova M, Sloncova E, Horazna M, Kriz V,
Machonova O, Jindrich J, Zdrahal Z, Bartunek P, Korinek V. 2014. Monensin inhibits canonical wnt signaling in
human colorectal Cancer cells and suppresses tumor growth in multiple intestinal neoplasia mice. Molecular
Cancer Therapeutics 13:812–822. doi: 10.1158/1535-7163.MCT-13-0625, PMID: 24552772
Vaeth M, Schliesser U, Mu¨ller G, Reissig S, Satoh K, Tuettenberg A, Jonuleit H, Waisman A, Mu¨ller MR, Serfling
E, Sawitzki BS, Berberich-Siebelt F. 2012. Dependence on nuclear factor of activated T-cells (NFAT) levels
discriminates conventional T cells from Foxp3+ regulatory T cells. PNAS 109:16258–16263. doi: 10.1073/pnas.
1203870109, PMID: 22991461
Vig M, Beck A, Billingsley JM, Lis A, Parvez S, Peinelt C, Koomoa DL, Soboloff J, Gill DL, Fleig A, Kinet JP,
Penner R. 2006a. CRACM1 multimers form the ion-selective pore of the CRAC channel. Current Biology 16:
2073–2079. doi: 10.1016/j.cub.2006.08.085, PMID: 16978865
Vig M, Peinelt C, Beck A, Koomoa DL, Rabah D, Koblan-Huberson M, Kraft S, Turner H, Fleig A, Penner R, Kinet
JP. 2006b. CRACM1 is a plasma membrane protein essential for store-operated Ca2+ entry. Science 312:
1220–1223. doi: 10.1126/science.1127883, PMID: 16645049
Vig M, Kinet JP. 2007. The long and arduous road to CRAC. Cell Calcium 42:157–162. doi: 10.1016/j.ceca.2007.
03.008, PMID: 17517435
Vig M, DeHaven WI, Bird GS, Billingsley JM, Wang H, Rao PE, Hutchings AB, Jouvin MH, Putney JW, Kinet JP.
2008. Defective mast cell effector functions in mice lacking the CRACM1 pore subunit of store-operated
calcium release-activated calcium channels. Nature Immunology 9:89–96. doi: 10.1038/ni1550, PMID: 18059270
Vig M, Kinet JP. 2009. Calcium signaling in immune cells. Nature Immunology 10:21–27. doi: 10.1038/ni.f.220,
PMID: 19088738
Wang Y, Deng X, Mancarella S, Hendron E, Eguchi S, Soboloff J, Tang XD, Gill DL. 2010. The calcium store
sensor, STIM1, reciprocally controls Orai and CaV1.2 channels. Science 330:105–109. doi: 10.1126/science.
1191086, PMID: 20929813
Wang L, Brautigan DL. 2013. a-SNAP inhibits AMPK signaling to reduce mitochondrial biogenesis and
dephosphorylates Thr172 in Ampka in vitro. Nature Communications 4:1559. doi: 10.1038/ncomms2565,
PMID: 23463002
Weigand KM, Swarts HG, Fedosova NU, Russel FG, Koenderink JB. 2012. Na,K-ATPase activity modulates src
activation: a role for ATP/ADP ratio. Biochimica Et Biophysica Acta (BBA) - Biomembranes 1818:1269–1273.
doi: 10.1016/j.bbamem.2012.01.015, PMID: 22290188
Wilhelm K, Ganesan J, Mu¨ller T, Du¨rr C, Grimm M, Beilhack A, Krempl CD, Sorichter S, Gerlach UV, Ju¨ttner E,
Zerweck A, Ga¨rtner F, Pellegatti P, Di Virgilio F, Ferrari D, Kambham N, Fisch P, Finke J, Idzko M, Zeiser R.
2010. Graft-versus-host disease is enhanced by extracellular ATP activating P2X7R. Nature Medicine 16:1434–
1438. doi: 10.1038/nm.2242, PMID: 21102458
Winslow MM, Neilson JR, Crabtree GR. 2003. Calcium signalling in lymphocytes. Current Opinion in
Immunology 15:299–307. doi: 10.1016/S0952-7915(03)00050-5, PMID: 12787755
Wu C, Yosef N, Thalhamer T, Zhu C, Xiao S, Kishi Y, Regev A, Kuchroo VK. 2013. Induction of pathogenic TH17
cells by inducible salt-sensing kinase SGK1. Nature 496:513–517. doi: 10.1038/nature11984, PMID: 23467085
Miao et al. eLife 2017;6:e25155. DOI: 10.7554/eLife.25155 22 of 23
Research article Immunology
Yip L, Woehrle T, Corriden R, Hirsh M, Chen Y, Inoue Y, Ferrari V, Insel PA, Junger WG. 2009. Autocrine
regulation of T-cell activation by ATP release and P2X7 receptors. The FASEB Journal 23:1685–1693. doi: 10.
1096/fj.08-126458, PMID: 19211924
Miao et al. eLife 2017;6:e25155. DOI: 10.7554/eLife.25155 23 of 23
Research article Immunology
